In an older hospitalized adult receiving proton‑pump inhibitors and broad‑spectrum antibiotics (or immunosuppressive therapy), what infectious organisms besides Clostridioides difficile can cause diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Infectious Causes of Diarrhea in Hospitalized Patients Beyond C. difficile

In hospitalized adults receiving proton-pump inhibitors and broad-spectrum antibiotics, routine stool cultures for bacterial pathogens (Salmonella, Shigella, Campylobacter) and ova/parasite examination should generally NOT be sent unless the patient was admitted with diarrhea, is HIV-positive, or is part of an outbreak investigation—these organisms rarely cause hospital-acquired diarrhea. 1

The "3-Day Rule" and Why Most Pathogens Don't Matter

Bacterial pathogens causing hospital-acquired diarrhea after 3 days of hospitalization are exceedingly rare. The yield of stool cultures for standard enteric pathogens (Salmonella, Shigella, Campylobacter, Yersinia) in patients developing diarrhea after 3 days of hospitalization is extremely low, and routine testing wastes resources without improving diagnostic accuracy. 1

Community-Acquired vs. Nosocomial Pathogens

The organisms that typically cause infectious diarrhea—Salmonella, Shigella, Campylobacter jejuni, Aeromonas, Yersinia, pathogenic E. coli, Entamoeba histolytica, and most viruses—are community-acquired diseases. 1 They only rarely cause infectious diarrhea acquired after hospital admission in immunocompetent patients. 1

When to Actually Test for Other Pathogens

Specific High-Risk Scenarios Requiring Broader Testing

You should send stool cultures and additional testing in these specific circumstances:

  • Patient admitted TO the hospital WITH diarrhea (not diarrhea that developed after admission) 1
  • HIV-infected or immunocompromised patients (including those on immunosuppressive therapy) 1
  • Age >65 years with comorbid disease or neutropenia 1
  • Part of a suspected nosocomial outbreak 1
  • Bloody diarrhea or inflammatory features (fever, tenesmus, fecal leukocytes, positive lactoferrin) 1

What to Test For in These High-Risk Patients

When testing IS indicated based on the above criteria:

  • Stool culture for Salmonella, Shigella, Campylobacter when bloody diarrhea is present 2, 3
  • Shiga toxin-producing E. coli (STEC) testing for bloody diarrhea or severe cramping 2
  • Ova and parasite examination for travelers or persistent symptoms 2
  • Pathogenic E. coli (including enterotoxigenic, enteropathogenic, and enterohemorrhagic strains) 1, 3
  • Rotavirus (particularly in immunocompromised patients) 3

Rare but Documented Nosocomial Pathogens

While exceedingly uncommon, certain organisms have been documented to cause antibiotic-associated diarrhea in hospitalized patients beyond C. difficile:

  • Clostridium perfringens (enterotoxin-producing strains) 4
  • Staphylococcus aureus (enterotoxin-producing strains) 4
  • Klebsiella oxytoca (associated with antibiotic-associated hemorrhagic colitis) 4

Important caveat: These organisms can also colonize healthy individuals, so their presence in stool does not automatically prove causation—clinical correlation is essential. 4

The Dominant Role of C. difficile

C. difficile accounts for 10-25% of all antibiotic-associated diarrhea cases and is by far the most common identifiable infectious cause of diarrhea in healthcare settings. 5, 2 In rehabilitation hospitals, C. difficile was found to be the etiologic agent in 25% of all patients evaluated for diarrhea and 39% of those specifically tested. 6 In contrast, no cases of Salmonella, Shigella, Campylobacter, or Yersinia were identified in that same population. 6

Synergistic Risk with PPIs

Proton pump inhibitors dramatically amplify C. difficile risk, particularly in patients receiving fewer antibiotics. Among hospitalized patients receiving only one antibiotic, PPI use increased C. difficile risk 15.7-fold; this effect diminished to 2.7-fold in patients receiving five or more antibiotics. 7 PPIs independently increase C. difficile risk 3.6-fold overall, and this risk is further elevated 4.5-fold in multivariable analyses. 7, 8

Practical Algorithm for Stool Testing

For hospitalized patients developing diarrhea:

  1. Always test for C. difficile toxin (single specimen, EIA for toxins A and B or two-step algorithm) 5, 2

  2. Skip routine bacterial cultures and O&P UNLESS:

    • Patient admitted WITH diarrhea 1
    • HIV-positive or immunocompromised 1
    • Age >65 with neutropenia or severe comorbidity 1
    • Bloody diarrhea present 2
    • Suspected outbreak 1
  3. If testing IS indicated, send:

    • Stool culture for Salmonella/Shigella/Campylobacter 2
    • STEC testing if bloody 2
    • O&P if travel history or persistent symptoms 2

Critical Pitfall to Avoid

Never use antimotility agents (loperamide, diphenoxylate) when C. difficile or any infectious diarrhea is suspected—these can precipitate toxic megacolon and mask disease progression. 5, 2, 9

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Assessment and Management of Diarrhea in Elderly Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnosis and Management of Clostridioides difficile Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Post-Treatment C. difficile with Persistent Symptoms in Long-Term Care

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Can proton pump inhibitors (PPIs) be given to a patient with Clostridioides difficile (C. diff) infection?
Can proton pump inhibitors (PPIs) cause Clostridioides difficile (C. diff) colitis in patients with a history of gastrointestinal issues or recent antibiotic use?
When a patient is on daptomycin (Daptomycin), should famotidine or a proton pump inhibitor (PPI) be used for managing gastrointestinal issues?
What is my risk level of having Clostridioides difficile (C. diff) infection given my recent Augmentin (amoxicillin-clavulanate) use and long-term Proton Pump Inhibitor (PPI) usage with Omeprazole?
What is the utility of stool cultures in the emergency department for evaluating patients with acute diarrhea, particularly in high-risk populations such as the elderly, young children, or immunocompromised (immunocompromised) individuals?
Should intravenous ferric carboxymaltose and intravenous zoledronic acid be administered on the same day, or spaced at least 24 hours apart to avoid renal stress, acute‑phase reactions, and hypophosphatemia?
How should a 12‑month‑old child with a hemoglobin of 4.8 g/dL be evaluated and managed?
What is the recommended intravenous ascorbic acid infusion rate and total dose for an adult with normal renal function and no contraindications?
Should omega‑3 fatty acid supplementation be used in a patient with type 2 diabetes mellitus (T2DM) and biopsy‑proven non‑alcoholic steatohepatitis (NASH) with stage F4 cirrhosis?
What is the most likely diagnosis and recommended workup for a 16‑year‑old overweight female with left‑sided pulsatile tinnitus relieved by firm pressure on the left carotid artery, mixed low‑frequency (250‑500 Hz) hearing loss in the left ear, type A tympanogram, and normal ipsilateral and contralateral acoustic reflexes?
Can Adderall (mixed‑amphetamine) or Concerta (extended‑release methylphenidate) cause anger or irritability in someone being treated for ADHD?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.